Variably expressive copy-number variants (CNVs) are characterized by extensive phenotypic 19 heterogeneity of neuropsychiatric phenotypes. Approaches to identify single causative genes for 20 these phenotypes within each CNV have not been successful. Here, we posit using multiple lines 21 of evidence, including pathogenicity metrics, functional assays of model organisms, and gene 22 expression data, that multiple genes within each CNV region are likely responsible for the 23 observed phenotypes. We propose that candidate genes within each region likely interact with 24 each other through shared pathways to modulate the individual gene phenotypes, emphasizing 25 the genetic complexity of CNV-associated neuropsychiatric features. 26 27 28
screened 22 homologs of 16p11.2 genes in zebrafish morpholino knockdown models, and 91 identified 20 homologs that contributed to morphological defects and abnormal behavior (37) . 92 Iyer et al. also screened homologs of 16p11.2 genes in Drosophila melaogaster using RNAi 93 knockdown, and found that 10 out of 14 homologs contributed to global developmental defects 94 as well as specific neuronal and cellular defects in the developing fly eye (46) . Further, mouse 95 models for 15 genes within the 16p11.2 region have been generated to test for defects in 96 development and neuronal behavior (45, (48) (49) (50) (68) (69) (70) (71) (72) (73) (74) (75) (76) (77) (78) (79) (80) . For example, Taok2 -/mice have 97 increased brain size, behavioral defects, and impaired synapse development (50), Kcdt13 +/mice 98 show defects in hippocampal synaptic transmission and decreased dendritic complexity (45),
99
Mapk3 +/mice show behavior anomalies, abnormal synapse function and reduced cell 100 proliferation during development (68, 69) , and Mvp +/mice show decreased plasticity and 101 synaptic defects in ocular neurons (48) (Figure 2B) . Importantly, these models of individual 102 genes do not fully recapitulate the phenotypes observed in models of the entire CNV (81-85).
103
For example, the decreased body weight, abnormal brain morphology and coordination defects 104 observed in 16p11.2 deletion mouse models have not been observed in any individual gene 105 knockdown models (81-84) (Figure 2B) . Similarly, Otud7a +/mouse models have low body 106 weight, reduced vocalization, abnormal dendritic spine morphology, and seizures, but the 107 15q13.3 deletion mice also show learning and memory defects in addition to the above features 108 (43, 44, 86) . Further, mouse models for Chrna7 +/-, another candidate gene on chromosome 109 15q13.3, only show subtle behavioral phenotypes (87). These data suggest that 110 haploinsufficiency of CHRNA7 or OTUD7A alone is not sufficient to account for the 111 pathogenicity of the entire CNV. Overall, a catalog of functional data from mouse (88), zebrafish genes were expressed in the embryonic forebrain, with six genes expressed in neuronal tissues 122 related to schizophrenia (39). In fact, a genome-wide weighted gene correlation network analysis 123 (WGCNA) (91) from different brain tissues during development (92) shows several large 124 modules of genes with similar expression patterns (Figure 3) . For example, the five largest 125 modules are each enriched (p<0.05 with Benjamini-Hochberg correction) for biological 126 functions related to neurodevelopment, including protein modification and transport in module 1 127 (M1), nervous system development in M2, and cell communication and signal transduction in 128 M5. Importantly, each of these modules contains multiple genes from the same CNV region, 129 including 3q29 genes PAK2, NCBP2, and BDH1 in M1, 1q21.1 genes BCL9, CHD1L and FMO5 130 in M2, and 16p11.2 genes MVP and QPRT in M5. Therefore, it is clear that multiple genes in the 131 same CNV region are co-expressed with each other in the developing brain and could share 132 similar functions or regulatory patterns.
134
Dissecting the genetic complexity of CNV pathogenicity 135 Several scenarios could explain how the haploinsufficiency of multiple genes can predict the 136 variable phenotypes associated with the entire CNV ( Figure 4A) . The simplest such model is an 137 additive model, where disruption of individual genes within a CNV may only impart a mild 138 phenotype on their own, but additively contribute to more severe features (93) (Figure 4A) . 139 However, an additive model may not always explain the phenotypic features manifested by 140 CNVs containing multiple candidate genes that could lead to severe defects or lethality on their 141 own. For example, heterozygous Tbx1 +/-(within the 22q11.2 region) and Mapk1 +/-(within the 142 distal 22q11.2 region) mice both lead to perinatal or neonatal lethality (94-96). In humans, 14% 143 (24/172) of CNV genes are under evolutionary constraint in control populations (pLI score >0.9 144 or maximum CCR score >99 th percentile) and have no reported disease-associated variants (97-145 99), suggesting that these genes could be under strong purifying selection (66). Further, 18%
146
(22/125) of CNV genes show evolutionary constraint for loss-of-function mutations (pLI>0.9) 147 but not for copy-number changes within a control population (100). We therefore hypothesize 148 that the pathogenicity of variably expressive CNVs can also be explained by complex pathway (45,50) and therefore are more likely to interact with each other than genes located in 161 different biological pathways. In fact, it has been shown that genes within pathogenic CNVs are 162 more similar in function compared to genes within benign CNVs, suggesting that variably 163 expressive CNVs are likely to contain interactions between functionally relevant genes (101).
164
Further, Noh and colleagues found an over-representation of interactions among genes within 165 autism-associated CNVs, and these interactions were enriched for synaptic transmission and 166 regulatory signaling pathways (102). Because of this, therapeutic targets for pathways shared 167 among CNV genes could be explored as potential treatments for CNV disorders. candidate genes in the same region. Because of this, a thorough systems-based approach for each 203 gene within a CNV and its interactions is necessary to identify candidate genes responsible for 204 the neuropsychiatric features of each region (106).
205
In summary, genomic and functional data have implicated multiple genes in variably 206 expressive CNV regions towards neuropsychiatric phenotypes, suggesting that single causative 207 genes are not responsible for the heterogeneous features of these CNVs. Here, we propose a 208 complex interaction-based model for these CNVs, where candidate genes within each region 209 interact with each other to influence the variable clinical outcome. The CNV phenotype is 210 therefore distinct from the phenotype manifested by any individual gene, or in some cases, the Competing interests 231 The authors declare that they have no financial or non-financial competing interests. and that the phenotype of pairwise knockdown AB is due to the additive effects of the two genes.
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